Contribution of host immunity to cyclophosphamide therapy of a chemically‐induced murine sarcoma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (34)
Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.
1960 • 736 citations
ANTIGENIC PROPERTIES OF CHEMICALLY INDUCED TUMORS*
1962 • 528 citations
Selective depletion of lymphoid tissue by cyclophosphamide.
1972 • 360 citations
Active Immunotherapy with Corynebacterium parvum and Chemotherapy in Murine Fibrosarcomas
1970 • 137 citations
Prolongation of Homograft Survival in Mice with Single Doses of Cyclophosphamide
1963 • 136 citations
Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
1969 • 131 citations
In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs
1968 • 127 citations
Treatment of Burkitt's tumor with cyclophosphamide
1970 • 122 citations
Parity and Optical Activity
1972 • 108 citations
Humoral and cellular factors in homograft and isograft immunity against sarcoma cells.
1960 • 87 citations
DEMONSTRATION OF CELL‐SURFACE ANTIGENS ON CHEMICALLY INDUCED TUMORS*
1971 • 58 citations
Immunotherapy of primary moloney sarcoma‐virus‐induced tumors
1970 • 52 citations
Immunological Studies in Patients With Placental Choriocarcinoma<xref ref-type="fn" rid="FN2">2</xref>
1964 • 49 citations
An immunochemotherapeutic system for the treatment of a transplanted Moloney virus-induced lymphoma in mice.
1969 • 39 citations
Selective suppression of humoral and cellular immunity with cytosine arabinoside.
1972 • 37 citations
Effect of combination treatment with cyclophosphamide and isogeneic or allogeneic spleen and bone marrow cells in leukemic (l1210) mice
1971 • 35 citations
Duration of Drug Levels in Mice as Indicated by Residual Antileukemic Efficacy
1968 • 32 citations
Host defence mechanisms in Burkitt's lymphoma and Kaposi's sarcoma: the clinical evidence.
1970 • 24 citations
Antitumor activity of cytoxan.
1961 • 23 citations
The Recovery of Immune Responsiveness after Treatment with Cyclophosphamide
1971 • 22 citations
Tumour specific antigens associated with chemically induced tumours.
1970 • 19 citations
Studies on the Antigenicity of Radiation-induced Murine Osteosarcomata
1972 • 19 citations
Host defense mechanisms in the regression of sarcoma 180 in pyridoxine-deficient mice.
1962 • 17 citations
Dependence of the regression of sarcoma 180 in vitamin B 6-deficient mice upon the immunologic competence of the host.
1967 • 17 citations
Immunological studies in patients with placental choriocarcinoma
1965 • 12 citations
The influence of host factors on cyclophosphamide treatment of Moloney virus-induced lymphomas
1970 • 10 citations
Chemotherapy of Solid Tumors
1970 • 9 citations
Antitumor Effects of Kethoxal-Bis(Thiosemicarbazone) and 6-Mercaptopurine in Neonatally Thymeetomized Mice.
1967 • 9 citations
Strain specificity of stimulated regression of sarcoma 180.
1965 • 9 citations
Host resistance against tumor and its synergic effect with cancer chemotherapy.
1967 • 6 citations
Effect of cyclophosphamide on syngeneic transplantation of para‐adenovirus‐7‐transformed tumor cells in hamsters
1972 • 6 citations
Effect of pertussis antigen and cyclophosphamide on myeloma tumor.
1970 • 5 citations
The chemical treatment of advanced cancer in man.
1967 • 4 citations
Relationship Between Tumor Incompatibility and Therapeutic Response.
1967 • 4 citations